Skip to main content
PMC home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1998 Apr-Jun;4(2):239–249. doi: 10.3201/eid0402.980211

Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future.

M M Huycke 1, D F Sahm 1, M S Gilmore 1
PMCID: PMC2640141  PMID: 9621194

Abstract

Enterococci, leading causes of nosocomial bacteremia, surgical wound infection, and urinary tract infection, are becoming resistant to many and sometimes all standard therapies. New rapid surveillance methods are highlighting the importance of examining enterococcal isolates at the species level. Most enterococcal infections are caused by Enterococcus faecalis, which are more likely to express traits related to overt virulence but--for the moment--also more likely to retain sensitivity to at least one effective antibiotic. The remaining infections are mostly caused by E. faecium, a species virtually devoid of known overt pathogenic traits but more likely to be resistant to even antibiotics of last resort. Effective control of multiple-drug resistant enterococci will require 1) better understanding of the interaction between enterococci, the hospital environment, and humans, 2) prudent antibiotic use, 3) better contact isolation in hospitals and other patient care environments, and 4) improved surveillance. Equally important is renewed vigor in the search for additional drugs, accompanied by the evolution of new therapeutic paradigms less vulnerable to the cycle of drug introduction and drug resistance.

Full Text

The Full Text of this article is available as a PDF (195.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arduino R. C., Jacques-Palaz K., Murray B. E., Rakita R. M. Resistance of Enterococcus faecium to neutrophil-mediated phagocytosis. Infect Immun. 1994 Dec;62(12):5587–5594. doi: 10.1128/iai.62.12.5587-5594.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arduino R. C., Murray B. E., Rakita R. M. Roles of antibodies and complement in phagocytic killing of enterococci. Infect Immun. 1994 Mar;62(3):987–993. doi: 10.1128/iai.62.3.987-993.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aumercier M., Bouhallab S., Capmau M. L., Le Goffic F. RP 59500: a proposed mechanism for its bactericidal activity. J Antimicrob Chemother. 1992 Jul;30 (Suppl A):9–14. doi: 10.1093/jac/30.suppl_a.9. [DOI] [PubMed] [Google Scholar]
  4. Booth M. C., Bogie C. P., Sahl H. G., Siezen R. J., Hatter K. L., Gilmore M. S. Structural analysis and proteolytic activation of Enterococcus faecalis cytolysin, a novel lantibiotic. Mol Microbiol. 1996 Sep;21(6):1175–1184. doi: 10.1046/j.1365-2958.1996.831449.x. [DOI] [PubMed] [Google Scholar]
  5. Bryan-Jones D. G., Whittenbury R. Haematin-dependent oxidative phosphorylation in Streptococcus faecalis. J Gen Microbiol. 1969 Oct;58(2):247–260. doi: 10.1099/00221287-58-2-247. [DOI] [PubMed] [Google Scholar]
  6. Bush L. M., Calmon J., Cherney C. L., Wendeler M., Pitsakis P., Poupard J., Levison M. E., Johnson C. C. High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections. Ann Intern Med. 1989 Apr 1;110(7):515–520. doi: 10.7326/0003-4819-110-7-515. [DOI] [PubMed] [Google Scholar]
  7. Caron F., Pestel M., Kitzis M. D., Lemeland J. F., Humbert G., Gutmann L. Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium. J Infect Dis. 1995 Jan;171(1):106–112. doi: 10.1093/infdis/171.1.106. [DOI] [PubMed] [Google Scholar]
  8. Chow J. W., Davidson A., Sanford E., 3rd, Zervos M. J. Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy. Clin Infect Dis. 1997 Jan;24(1):91–92. doi: 10.1093/clinids/24.1.91. [DOI] [PubMed] [Google Scholar]
  9. Chow J. W., Donahedian S. M., Zervos M. J. Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia. Clin Infect Dis. 1997 Jan;24(1):90–91. doi: 10.1093/clinids/24.1.90. [DOI] [PubMed] [Google Scholar]
  10. Chow J. W., Kuritza A., Shlaes D. M., Green M., Sahm D. F., Zervos M. J. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. J Clin Microbiol. 1993 Jun;31(6):1609–1611. doi: 10.1128/jcm.31.6.1609-1611.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chow J. W., Thal L. A., Perri M. B., Vazquez J. A., Donabedian S. M., Clewell D. B., Zervos M. J. Plasmid-associated hemolysin and aggregation substance production contribute to virulence in experimental enterococcal endocarditis. Antimicrob Agents Chemother. 1993 Nov;37(11):2474–2477. doi: 10.1128/aac.37.11.2474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Clark N. C., Cooksey R. C., Hill B. C., Swenson J. M., Tenover F. C. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother. 1993 Nov;37(11):2311–2317. doi: 10.1128/aac.37.11.2311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cohen M. A., Yoder S. L., Huband M. D., Roland G. E., Courtney C. L. In vitro and in vivo activities of clinafloxacin, CI-990 (PD 131112), and PD 138312 versus enterococci. Antimicrob Agents Chemother. 1995 Sep;39(9):2123–2127. doi: 10.1128/aac.39.9.2123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cohen M. L. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science. 1992 Aug 21;257(5073):1050–1055. doi: 10.1126/science.257.5073.1050. [DOI] [PubMed] [Google Scholar]
  15. Collins L. A., Malanoski G. J., Eliopoulos G. M., Wennersten C. B., Ferraro M. J., Moellering R. C., Jr In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms. Antimicrob Agents Chemother. 1993 Mar;37(3):598–601. doi: 10.1128/aac.37.3.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Devriese L. A., Pot B., Collins M. D. Phenotypic identification of the genus Enterococcus and differentiation of phylogenetically distinct enterococcal species and species groups. J Appl Bacteriol. 1993 Nov;75(5):399–408. doi: 10.1111/j.1365-2672.1993.tb02794.x. [DOI] [PubMed] [Google Scholar]
  17. Edmond M. B., Ober J. F., Dawson J. D., Weinbaum D. L., Wenzel R. P. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis. 1996 Dec;23(6):1234–1239. doi: 10.1093/clinids/23.6.1234. [DOI] [PubMed] [Google Scholar]
  18. Edmond M. B., Ober J. F., Weinbaum D. L., Pfaller M. A., Hwang T., Sanford M. D., Wenzel R. P. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis. 1995 May;20(5):1126–1133. doi: 10.1093/clinids/20.5.1126. [DOI] [PubMed] [Google Scholar]
  19. Eliopoulos G. M., Wennersten C. B., Cole G., Moellering R. C. In vitro activities of two glycylcyclines against gram-positive bacteria. Antimicrob Agents Chemother. 1994 Mar;38(3):534–541. doi: 10.1128/aac.38.3.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Emori T. G., Gaynes R. P. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev. 1993 Oct;6(4):428–442. doi: 10.1128/cmr.6.4.428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gilmore M. S., Segarra R. A., Booth M. C. An HlyB-type function is required for expression of the Enterococcus faecalis hemolysin/bacteriocin. Infect Immun. 1990 Dec;58(12):3914–3923. doi: 10.1128/iai.58.12.3914-3923.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Goldmann D., Larson E. Hand-washing and nosocomial infections. N Engl J Med. 1992 Jul 9;327(2):120–122. doi: 10.1056/NEJM199207093270211. [DOI] [PubMed] [Google Scholar]
  23. Haley R. W., Culver D. H., White J. W., Morgan W. M., Emori T. G., Munn V. P., Hooton T. M. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol. 1985 Feb;121(2):182–205. doi: 10.1093/oxfordjournals.aje.a113990. [DOI] [PubMed] [Google Scholar]
  24. Handwerger S., Raucher B., Altarac D., Monka J., Marchione S., Singh K. V., Murray B. E., Wolff J., Walters B. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis. 1993 Jun;16(6):750–755. doi: 10.1093/clind/16.6.750. [DOI] [PubMed] [Google Scholar]
  25. Hillyard D. R. The molecular approach to microbial diagnosis. Am J Clin Pathol. 1994 Apr;101(4 Suppl 1):S18–S21. [PubMed] [Google Scholar]
  26. Hiramatsu K., Hanaki H., Ino T., Yabuta K., Oguri T., Tenover F. C. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother. 1997 Jul;40(1):135–136. doi: 10.1093/jac/40.1.135. [DOI] [PubMed] [Google Scholar]
  27. Horodniceanu T., Bougueleret L., El-Solh N., Bieth G., Delbos F. High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. zymogenes. Antimicrob Agents Chemother. 1979 Nov;16(5):686–689. doi: 10.1128/aac.16.5.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Hughes J. M., Culver D. H., White J. W., Jarvis W. R., Morgan W. M., Munn V. P., Mosser J. L., Emori T. G. Nosocomial infection surveillance, 1980-1982. MMWR CDC Surveill Summ. 1983;32(4):1SS–16SS. [PubMed] [Google Scholar]
  29. Huycke M. M., Gilmore M. S. Frequency of aggregation substance and cytolysin genes among enterococcal endocarditis isolates. Plasmid. 1995 Sep;34(2):152–156. doi: 10.1006/plas.1995.9992. [DOI] [PubMed] [Google Scholar]
  30. Huycke M. M., Joyce W., Wack M. F. Augmented production of extracellular superoxide by blood isolates of Enterococcus faecalis. J Infect Dis. 1996 Mar;173(3):743–746. doi: 10.1093/infdis/173.3.743. [DOI] [PubMed] [Google Scholar]
  31. Huycke M. M., Spiegel C. A., Gilmore M. S. Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis. Antimicrob Agents Chemother. 1991 Aug;35(8):1626–1634. doi: 10.1128/aac.35.8.1626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Ike Y., Clewell D. B. Genetic analysis of the pAD1 pheromone response in Streptococcus faecalis, using transposon Tn917 as an insertional mutagen. J Bacteriol. 1984 Jun;158(3):777–783. doi: 10.1128/jb.158.3.777-783.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Ike Y., Clewell D. B., Segarra R. A., Gilmore M. S. Genetic analysis of the pAD1 hemolysin/bacteriocin determinant in Enterococcus faecalis: Tn917 insertional mutagenesis and cloning. J Bacteriol. 1990 Jan;172(1):155–163. doi: 10.1128/jb.172.1.155-163.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ike Y., Hashimoto H., Clewell D. B. Hemolysin of Streptococcus faecalis subspecies zymogenes contributes to virulence in mice. Infect Immun. 1984 Aug;45(2):528–530. doi: 10.1128/iai.45.2.528-530.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ike Y., Hashimoto H., Clewell D. B. High incidence of hemolysin production by Enterococcus (Streptococcus) faecalis strains associated with human parenteral infections. J Clin Microbiol. 1987 Aug;25(8):1524–1528. doi: 10.1128/jcm.25.8.1524-1528.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Jett B. D., Huycke M. M., Gilmore M. S. Virulence of enterococci. Clin Microbiol Rev. 1994 Oct;7(4):462–478. doi: 10.1128/cmr.7.4.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Jett B. D., Jensen H. G., Atkuri R. V., Gilmore M. S. Evaluation of therapeutic measures for treating endophthalmitis caused by isogenic toxin-producing and toxin-nonproducing Enterococcus faecalis strains. Invest Ophthalmol Vis Sci. 1995 Jan;36(1):9–15. [PubMed] [Google Scholar]
  38. Jett B. D., Jensen H. G., Nordquist R. E., Gilmore M. S. Contribution of the pAD1-encoded cytolysin to the severity of experimental Enterococcus faecalis endophthalmitis. Infect Immun. 1992 Jun;60(6):2445–2452. doi: 10.1128/iai.60.6.2445-2452.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Jones R. N., Johnson D. M., Erwin M. E. In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones. Antimicrob Agents Chemother. 1996 Mar;40(3):720–726. doi: 10.1128/aac.40.3.720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Kaye D. Enterococci. Biologic and epidemiologic characteristics and in vitro susceptibility. Arch Intern Med. 1982 Oct 25;142(11):2006–2009. doi: 10.1001/archinte.142.11.2006. [DOI] [PubMed] [Google Scholar]
  41. Klare I., Heier H., Claus H., Reissbrodt R., Witte W. vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett. 1995 Jan 15;125(2-3):165–171. doi: 10.1111/j.1574-6968.1995.tb07353.x. [DOI] [PubMed] [Google Scholar]
  42. Leclercq R., Derlot E., Duval J., Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988 Jul 21;319(3):157–161. doi: 10.1056/NEJM198807213190307. [DOI] [PubMed] [Google Scholar]
  43. Livornese L. L., Jr, Dias S., Samel C., Romanowski B., Taylor S., May P., Pitsakis P., Woods G., Kaye D., Levison M. E. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med. 1992 Jul 15;117(2):112–116. doi: 10.7326/0003-4819-117-2-112. [DOI] [PubMed] [Google Scholar]
  44. Montecalvo M. A., Horowitz H., Gedris C., Carbonaro C., Tenover F. C., Issah A., Cook P., Wormser G. P. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother. 1994 Jun;38(6):1363–1367. doi: 10.1128/aac.38.6.1363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Morris J. G., Jr, Shay D. K., Hebden J. N., McCarter R. J., Jr, Perdue B. E., Jarvis W., Johnson J. A., Dowling T. C., Polish L. B., Schwalbe R. S. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med. 1995 Aug 15;123(4):250–259. doi: 10.7326/0003-4819-123-4-199508150-00002. [DOI] [PubMed] [Google Scholar]
  46. Murray B. E., Singh K. V., Markowitz S. M., Lopardo H. A., Patterson J. E., Zervos M. J., Rubeglio E., Eliopoulos G. M., Rice L. B., Goldstein F. W. Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states. J Infect Dis. 1991 Apr;163(4):780–785. doi: 10.1093/infdis/163.4.780. [DOI] [PubMed] [Google Scholar]
  47. Noble W. C., Virani Z., Cree R. G. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett. 1992 Jun 1;72(2):195–198. doi: 10.1016/0378-1097(92)90528-v. [DOI] [PubMed] [Google Scholar]
  48. Norris A. H., Reilly J. P., Edelstein P. H., Brennan P. J., Schuster M. G. Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. Clin Infect Dis. 1995 May;20(5):1137–1144. doi: 10.1093/clinids/20.5.1137. [DOI] [PubMed] [Google Scholar]
  49. Noskin G. A., Stosor V., Cooper I., Peterson L. R. Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces. Infect Control Hosp Epidemiol. 1995 Oct;16(10):577–581. doi: 10.1086/647011. [DOI] [PubMed] [Google Scholar]
  50. Pritchard G. G., Wimpenny J. W. Cytochrome formation, oxygen-induced proton extrusion and respiratory activity in Streptococcus faecalis var. zymogenes grown in the presence of haematin. J Gen Microbiol. 1978 Jan;104(1):15–22. doi: 10.1099/00221287-104-1-15. [DOI] [PubMed] [Google Scholar]
  51. Quale J., Landman D., Saurina G., Atwood E., DiTore V., Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis. 1996 Nov;23(5):1020–1025. doi: 10.1093/clinids/23.5.1020. [DOI] [PubMed] [Google Scholar]
  52. Rhinehart E., Smith N. E., Wennersten C., Gorss E., Freeman J., Eliopoulos G. M., Moellering R. C., Jr, Goldmann D. A. Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med. 1990 Dec 27;323(26):1814–1818. doi: 10.1056/NEJM199012273232606. [DOI] [PubMed] [Google Scholar]
  53. Rice E. W., Messer J. W., Johnson C. H., Reasoner D. J. Occurrence of high-level aminoglycoside resistance in environmental isolates of enterococci. Appl Environ Microbiol. 1995 Jan;61(1):374–376. doi: 10.1128/aem.61.1.374-376.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Ritchey T. W., Seeley H. W. Cytochromes in Streptococcus faecalis var. zymogenes grown in a haematin-containing medium. J Gen Microbiol. 1974 Dec;85(2):220–228. doi: 10.1099/00221287-85-2-220. [DOI] [PubMed] [Google Scholar]
  55. Ritchey T. W., Seely H. W., Jr Distribution of cytochrome-like respiration in streptococci. J Gen Microbiol. 1976 Apr;93(2):195–203. doi: 10.1099/00221287-93-2-195. [DOI] [PubMed] [Google Scholar]
  56. Sapico F. L., Canawati H. N., Ginunas V. J., Gilmore D. S., Montgomerie J. Z., Tuddenham W. J., Facklam R. R. Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem? J Clin Microbiol. 1989 Sep;27(9):2091–2095. doi: 10.1128/jcm.27.9.2091-2095.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Uttley A. H., Collins C. H., Naidoo J., George R. C. Vancomycin-resistant enterococci. Lancet. 1988 Jan 2;1(8575-6):57–58. doi: 10.1016/s0140-6736(88)91037-9. [DOI] [PubMed] [Google Scholar]
  58. Vollaard E. J., Clasener H. A. Colonization resistance. Antimicrob Agents Chemother. 1994 Mar;38(3):409–414. doi: 10.1128/aac.38.3.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Williamson R., le Bouguénec C., Gutmann L., Horaud T. One or two low affinity penicillin-binding proteins may be responsible for the range of susceptibility of Enterococcus faecium to benzylpenicillin. J Gen Microbiol. 1985 Aug;131(8):1933–1940. doi: 10.1099/00221287-131-8-1933. [DOI] [PubMed] [Google Scholar]
  60. Zervos M. J., Kauffman C. A., Therasse P. M., Bergman A. G., Mikesell T. S., Schaberg D. R. Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. Ann Intern Med. 1987 May;106(5):687–691. doi: 10.7326/0003-4819-106-5-687. [DOI] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES